Institute for Medical Education and Research, Madelyn Trupkin Herzfeld, IMER, imer, imier, Miami, Florida, Nursing CE's, Nursing contact hours, nursing education, continuing education, medical research and education, Oncology, Postgraduate credit, oncology nurses, nurses, symposia, symposium, online educational credit, Breast Cancer, Cancer, cancer, breast cancer, colorectal cancer, Colorectal Cancer, Targeting EGFR, EGFR Inhibitors, egfr inhibitors, head and neck cancer, Anti-VEGF, VEGF Inhibitors, vegf inhibitors, lung cancer, head cancer, CINV, cinv, Chemotherapy Induced Nausea & Vomiting, chemotherapy, nausea, vomiting, mucositis, cancer pain, chronic pain  
EPOTHILONE CHEMOTHERAPIES FOR METASTATIC BREAST CANCER: WHAT, WHEN, AND HOW?
   
  CE REGIONAL MEETINGS FOR ONCOLOGY NURSES

IMER Regional Meeting

Epothilone Chemotherapies for Metastatic Breast Cancer: What, When, and How?

Sponsored by:

IMER

 

Click here to request this program for your organization.
Person Requesting Form:

Contact name/administrative representative (if different from above):
Organization:
Street Address:
City:
State:
Zip:
Contact Phone:
Contact Fax:
Contact Email:
Expected Audience Composition:
Expected Number of Attendees:
Date and time of requested program (1st choice):
Date and time of requested program (2nd choice):
Date and time of requested program (3rd choice):

Thank you for your request.

We will contact you within 2 business days.

Download the request a date formClick Here to Download a Request an Educational Program Form (PDF)

 

Target Audience

This activity has been designed to meet the educational needs of advanced practice nurses and oncology nurses in caring for patients with breast cancer.

Purpose

To educate oncology nurses on new treatments for metastatic breast cancer including administration guidelines for epothilone chemotherapy and the management of patients receiving them.

Program Overview

Epothilone chemotherapy has recently been approved by the FDA for the treatment of metastatic breast cancer. In this regional CE dinner program, breast cancer nurse experts will address issues pertaining to the use of these agents in clinical practice. An overview of epothilones and their ability to overcome multidrug resistance will be described using 3-D video animation. There will also be a review of the mechanism of action of epothilone chemotherapy and a discussion of administration guidelines. The latter part of the presentation will focus on concerns specific to oncology nurses. Questions addressed will include: How do we safely administer epothilones? What side effects should we anticipate? How will we assess and manage these side effects? Program attendees will receive side-effect assessment and management clinical tools, as well as sample patient education materials, to utilize in their individual clinical practices. Clinical tools incorporated into the syllabus and discussed during the program will include:

  • Dosing schedules for new agents
  • Administration instructions for new agents
  • Assessment/management of peripheral neuropathies
  • Comorbidity considerations: Congestive heart failure, diabetes
  • Assessment/management of hypersensitivity reactions
  • Assessment/management of neutropenia
  • Assessment/management of palmar-plantar erythrodysesthesia

Learning Objectives

Upon completion of this program, participants should be better able to:

  • Review current standards of care for metastatic breast cancer
  • Differentiate the mechanisms of action of drugs affecting microtubules
  • Identify recent clinical trial results on the use of epothilones in metastatic breast cancer
  • Describe the side-effect profiles of epothilones used to treat patients with breast cancer
  • Describe appropriate nursing management of patients receiving epothilones

Chairperson

Georgia E. Litsas, MSN, RN, APRN, BC, AOCNP®
Dana-Farber Cancer Institute

 

This activity is sponsored by:

IMER Logo

There is no fee for this educational activity.

This activity is supported by an independent educational grant from Bristol-Myers Squibb Company.
 

Additional CE Meetings on This Topic:

Click on the column headers to sort and on a city for more details.
{date} {city} {speaker}
{icon}
{location}

More meetings to be added in the near future. Check for updates.

Program Agenda

Program Overview 5 minutes
Therapeutic Landscape for Metastatic Breast Cancer 10 minutes
What Are Epothilones and How Do They Overcome Multidrug Resistance? 10 minutes
When Are Epothilones Used in the Treatment of Metastatic Breast Cancer? 15 minutes
How Are Epothilones Administered? What Are Their Side Effects and How Are They Managed? 15 minutes
Questions & Answers 5 minutes

Disclosure of Conflicts of Interest

The Institute for Medical Education & Research (IMER) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by IMER for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accreditation Statements

This educational activity for 1.0 contact hour will be provided by IMER. IMER is an approved provider of continuing education by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This program has been approved for 1.0 contact hour(s) of continuing education by the American Academy of Nurse Practitioners. Program ID 0807340.

IMER is approved by the California Board of Registered Nursing, Provider Number 14763 for 1.2 contact hours.

A statement of credit will be issued only upon receipt of a completed activity evaluation form.